Get started
Author

Tinie van Boekel

Observed names: T van Boekel, Tinie Van Boekel
ORCID: 0009-0005-3152-6720
Observed ORCID: 0009-0005-3152-6720
OpenAlex ID: A5086850545
Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjögren's syndrome
2006 · D Sène, P Ghillani-Dalbin, et al. · Annals of the Rheumatic Diseases · 85
PDF
Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2023 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al. · Molecular Cancer Therapeutics · 13
PDF
Sensitivity and Drug Tolerance of Antidrug Antibody Assays in Relation to Positive Control Characteristics
2018 · David Egging, Jos Verhagen, et al. · Bioanalysis · 13
PDF
Use of surrogate matrices in bioanalytical preclinical safety testing using immunoassay methods: a recommendation from the European Bioanalysis Forum
2025 · Richard Hughes, Gregor Jordan, et al. · Bioanalysis · 2
An update on the European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: biomarker and anti-drug-antibody assays
2026 · Michael Wright, Richard Hughes, et al. · Bioanalysis · 1
PDF
Supplementary Data from Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2025 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Supplementary Data from Preclinical profile of BYON3521 predicts an effective and safe c-MET-antibody-drug conjugate
2024 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Supplementary Data from Preclinical profile of BYON3521 predicts an effective and safe c-MET-antibody-drug conjugate
2024 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Data from Preclinical profile of BYON3521 predicts an effective and safe c-MET-antibody-drug conjugate
2024 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Supplementary Data from Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2023 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Supplementary Data from Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2023 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Supplementary Data from Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2023 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Data from Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2023 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Works count: 13
Citation count: 114
H-index: 3
I10-index: 3
Year
Topic
Type